“Molecular characterization of a patient presumed to have prader-willi syndrome”
Falaleeva M, Sulsona CR, Zielke HR, Currey KM, de la Grange P, Aslanzadeh V, Driscoll DJ, Stamm S. Clin Med Insights Case Rep. 2013 May
Categories: Article
Article
In J Exp Clin Cancer Res: Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette Read more…